Indole sPLA2 inhibitors

An indole compound represented by the formula (I), or a pharmaceutically acceptable salt, or solvate derivative thereof;

• wherein;
• R1 is the group —(L1)—R11, where, —(L1)— is —(CH2)— and R11 is C7-C20 alkyl, C7-C20 haloalkyl, C7-C20 alkenyl, C7-C20 alkynyl, or a carbocyclic radical;
• R2 is —CH3 or C2H5;
• R3 is —C(O)—C(O)—NH2;
• R4 is the group —(La)-(acylsulfonamide group) where —(La)— is —O—CH2— and the acylsulfonamide group is —C(O)—CH—S(O)(O)—R81 and R81 is —CF3, CH3 or C2H5;
• R5 is hydrogen;
• and
• R6 and R7 are hydrogen, or a carbocyclic radical.